← Back to Clinical Trials
Recruiting NCT05284006

Non-invasive Functional Assessment and Pathogenesis of Morquio A

Trial Parameters

Condition Mucopolysaccharidosis IV Type A
Sponsor Nemours Children's Clinic
Study Type OBSERVATIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2021-05-01
Completion 2026-04-30
Interventions
Imaging, gait analysis, growth, joint test, hearing test, questionnaire, etc.

Brief Summary

Morquio A disease is a devastating systemic skeletal disease in which detailed progression and pathogenesis remain unknown. The proposed project aims to establish a non-invasive objective assessment that can be applicable to all ages of patients to better understand the progress of their disease and the most serious clinical problems (cervical instability and stenosis, tracheal obstruction, hyperlaxity of joints, hip dysplasia, and small lung capacity). The outcome of this project will lead to a more precise understanding of the skeletal/pulmonary compromise and defining clinical endpoints in this disease for future clinical trials of current or developing therapies.

Eligibility Criteria

Inclusion Criteria: * Patients affected by MPS IVA. The diagnosis of MPS IVA is confirmed by deficient enzyme activity of \< 5% of normal activity level as measured in plasma or leukocytes. Exclusion Criteria: * No

Related Trials